Photo Rounds

Patches of tough skin

A 35-year-old woman was concerned about areas of shiny tough skin in patches over her abdomen. She was otherwise in good health and was puzzled by this new condition. She said that the skin felt slightly uncomfortable, but was not painful.

What's your diagnosis?


 

The physician performed a 4-mm punch biopsy that confirmed the clinical suspicion of morphea (localized scleroderma).

Treatment options include high-potency topical glucocorticoids and topical calcipotriol (topical vitamin D). Localized scleroderma appears to soften with ultraviolet-A light therapy. Antihistamines and oral doxepin may be used to treat pruritus.

In this case, the patient was treated with topical clobetasol; she experienced some improvement in skin quality and symptoms. An antinuclear antibody test was positive, but she had not developed progressive systemic sclerosis.

Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ. Scleroderma and morphea. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. The Color Atlas of Family Medicine. New York, NY: McGraw-Hill;2009:778-783.

To learn more about The Color Atlas of Family Medicine, see:

* http://www.amazon.com/Color-Atlas-Family-Medicine/dp/0071474641

The Color Atlas of Family Medicine is also available as an app for mobile devices, see:

* http://usatinemedia.com/

Recommended Reading

Daily Azithromycin Cut Acute COPD Exacerbations in High-Risk Patients
MDedge Family Medicine
San Francisco Puts Circumcision Ban on Nov. Ballot
MDedge Family Medicine
Rosiglitazone to Be Available Only by Mail Order, FDA Says
MDedge Family Medicine
Therapeutic Hypothermia Can Treat Cardiac Arrest in Hypertrophic Cardiomyopathy
MDedge Family Medicine
Swimmer's Ear Triggered 2.4 Million Treatment Visits
MDedge Family Medicine
Provider Recommendation Key in HPV Vaccine Initiation
MDedge Family Medicine
Screening of Florida Teens Finds Hypertension, Obesity, Abnormal ECGs
MDedge Family Medicine
Incidence of Pacemaker Infections Rising in U.S.
MDedge Family Medicine
In the Pipeline: Cabozantinib Shown to Control Tumors and Bone Metastases
MDedge Family Medicine
FDA Panel Divided on Trilipix Labeling Changes
MDedge Family Medicine